Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with pancreatic cancer that has not spread to other parts of the body, who are about to start chemotherapy before surgery
- People aged 18 or older
- People who speak English or Spanish
- People who are willing and able to sign a consent form agreeing to take part
- People whose doctor has given clearance for them to take part in an exercise program
- People who are free from heart, lung, bone, or joint conditions that would prevent moderate physical activity
- People who currently do 60 minutes or less of structured moderate or vigorous exercise per week
- People who have not smoked in the past 12 months
- People who are willing and able to travel to Dana-Farber Cancer Institute (DFCI) for study assessments
Who may not be able to join:
- People with uncontrolled illnesses, such as an active infection, uncontrolled diabetes, uncontrolled high blood pressure, or uncontrolled thyroid disease
- People currently taking part in another clinical trial involving an investigational treatment
- People who have another active cancer in addition to pancreatic cancer
- People whose pancreatic cancer has spread to other parts of the body
- People with a history of bone, muscle, heart, lung, or neurological conditions that would prevent them from exercising
- People expected to receive additional cancer treatments during the study period
- People who currently do more than 60 minutes of structured moderate or vigorous exercise per week
- People who currently smoke
- People who are pregnant, due to unknown effects of exercise on a developing baby
- People the study investigator believes may not be able to safely follow the study's monitoring requirements (confirm with trial site)
- People who are unable to travel to DFCI for assessments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christina M Dieli-Conwright, PhD, MPH, Dana-Farber Cancer Institute
Phone: 617-582-8321
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Exercise Session Attendance Rate; Protein Supplementation (PS) Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.